Sanofi and Regeneron Restructure Immuno-Oncology Collaboration for Discovery and Development Programs 글 내용 전체보기
European Commission Approval for Orphan Drug NaMuscla® for the Treatment of Myotonia in Non-Dystrophic Myotonic Disorders 글 내용 전체보기
Continues Its Expansion: Hires Two Key Executives to Deepen Service Offerings and Expertise Around Value-Based Contracting 글 내용 전체보기
Blue Cross Blue Shield of Massachusetts Adds Two New Digital Health Solutions for Large Self-insured Clients 글 내용 전체보기
Val Verde Regional Medical Center Partners with Allen Technologies for Advanced Patient Engagement Tools 글 내용 전체보기
San Diego Blood Chip Maker BioFluidica Awarded Two NIH/NCI Grants for Isolation of Cell-Free DNA and Exosomes on Its Single Liquid Biopsy Platform 글 내용 전체보기
Forbius Announces the First Patient Dosed in a Phase 1 Oncology Trial of AVID200, a Novel TGF-beta 1 & 3 Inhibitor 글 내용 전체보기
